-+ 0.00%
-+ 0.00%
-+ 0.00%

BRIEF-Cabaletta Bio Announces 2027 Rese-Cel BLA Submission Anticipated In Myositis Following Recent FDA Alignment On Registrational Cohorts

Reuters·05/15/2025 11:34:55

Please log in to view news